BETTER in Academia: A glimpse into a BETTER future

This year, the Institute of molecular genetics and genetic engineering, University of Belgrade had the privilege of hosting a compelling lecture by dr Maja Stojiljkovic on the BETTER Project, offering molecular biology students an opportunity to observe the merging of healthcare and advanced technology.

Dr Stojiljkovic, participant of the BETTER project, talked about the idea of bringing the algorithms to the data by using Distributed Analytics (DA) which has great benefits such as the fact that data remains in the control of the data providers and research can leverage otherwise inaccessible data. By combining distributed artificial intelligence (federated learning) with health data including genomics of the three medical used cases, the project aims to develop innovative tools to support medical staff which will ultimately lead to improvement of citizen’s health outcome. Ensuring that the project remains compliant with GDPR standards was a key point of discussion, highlighting the commitment to privacy and ethical considerations in health data usage.

The lecture concluded with an interactive Q&A session, where students posed insightful questions about the project’s implementation and future developments, indicating a strong interest in how The BETTER Project could shape the future of healthcare research and practice in Europe and worldwide.


- Institute of molecular genetics and genetic engineering (IMGGE), 2024

IMG_9345
IMG_9348
IMG_9350
IMG_9354
IMG_9359

Please accept our cookies. Data is collected with respect for privacy. All requests to third party servers are anonymised so no user-identifying information is shared.

Funded by the EU

UKRI
The project has received funding from the European Union's Horizon Europe research and innovation programme under grant agreement No 101136262. The communication reflects only the author's view and the Commission is not responsible for any use that may be made of the information it contains.

Privacy Policy

Follow us:
linkedin
Twitter/X